查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762527

遠距病人監護市場：產業趨勢與全球預測 - 依軟體類型、應用領域、治療領域、產品/軟體用途、商業模式、主要地區

Remote Patient Monitoring Market: Industry Trends and Global Forecasts -Distribution by Type of Software, Application Area, Therapeutic Area, Product / Software Purpose, Type of Business Model, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

遠距病人監護市場：概覽

預計到2035年，全球遠距病人監護市場規模將從目前的94億美元成長至880億美元，在預測期內，年複合成長率將達到25%。

市場規模與機會分析依下列參數細分：

軟體類型

  • 系統即軟體
  • 系統即服務

應用

  • 血糖
  • 血壓
  • 體溫
  • 心電圖
  • 血氧飽和度
  • 呼吸速率
  • 其他

治療領域

  • 心血管疾病
  • 傳染病
  • 代謝性疾病
  • 腫瘤疾病
  • 呼吸系統疾病
  • 其他

產品/解決方案軟體用途

  • 商業用途
  • 臨床用途

商業模式

  • B2B
  • B2C

主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東和北非
  • 拉丁美洲

遠距病人監護市場：成長與趨勢

多年來，糖尿病、自體免疫疾病、心臟病等慢性疾病的盛行率疾病和癌症的發生率顯著上升。事實上，根據密西根大學慢性病管理中心最近發布的報告，超過50%的美國人口患有某種慢性疾病。這迫切需要透過頻繁的監測來管理疾病的跡象。然而，一些患者未能及時向醫療保健提供者報告他們的健康問題，導致嚴重後果並增加醫療保健成本。在此背景下，遠端患者監控應運而生，成為一種潛在的解決方案，使醫療保健提供者能夠在家庭護理環境中監測重要的健康體徵。

遠端病患監控市場-IMG1

遠端病患監測（RPM）的概念始於近200年前的19世紀。然而，直到雲端運算的出現，該領域才有了顯著的發展。事實上，遠距病患監護解決方案正逐漸融入醫療保健的主流，尤其是在新冠疫情封鎖期間。這些先進的工具和軟體解決方案使在此期間患者的健康監護成為可能，並顯著簡化了監護流程。這些先進的設備利用人工智慧和生物感測器即時監測生命體徵，例如血氧值、血壓、心率、呼吸頻率、血糖值以及其他重要體徵。目前，多家公司正致力於開發遠距患者監護系統。

遠距病患監護市場：關鍵洞察

本報告深入探討了遠距患者監護市場的現狀，並識別了該行業的潛在成長機會。主要調查結果包括：

  • 目前，超過 170 家公司聲稱擁有提供用於各種應用領域的遠距患者監護解決方案的必要能力。
  • 用於遠距患者監護的工具/軟體解決方案與各種類型的軟體一起研發，目的是針對不同的治療領域。
遠端病人監護市場-IMG2
  • 為了獲得競爭優勢，遠距病人監護解決方案開發商正積極致力於將高階功能整合到其解決方案和合作夥伴產品中。
  • 多年來，業內參與者已達成多項協議，以進一步開發和改進其專有軟體解決方案。
  • 為了支持該領域的持續創新，私人和公共投資者已進行總計 25億美元的重大資本投資。
  • 由於新冠疫情期間各種遠距病人監護解決方案的需求大幅成長，預計到2030年，整體市場將以超過25%的年複合成長率成長。
遠端病人監護市場-IMG3
  • 預計機會將平均分佈於各個應用領域、商業模式類型和主要地理區域。

遠距病人監護市場：關鍵細分市場

依軟體類型劃分，市場分為系統即軟體（SaaS）和系統即服務（SaaS）。目前，系統即軟體（SaaS）細分市場在全球遠距病人監護市場中佔有最大佔有率。此外，由於對基於雲端的解決方案的需求不斷成長，預計系統即服務（SaaS）細分市場中的遠距病人監護市場將在預測期內實現最高的市場成長。

依應用領域劃分，市場分為血糖、血壓、體溫、心電圖、血氧飽和度、呼吸頻率等。目前，心電圖細分市場在全球遠距病人監護市場中佔有最大佔有率。這是由於心血管疾病的盛行率不斷上升，需要持續監測重要的健康參數。此外，心電圖市場預計在預測期內將以更高的年複合成長率成長。

依治療領域劃分，市場分為心血管疾病、傳染病、代謝性疾病、腫瘤疾病、呼吸系統疾病等。目前，代謝性疾病細分市場在全球遠距病人監護市場中佔有最大佔有率。然而，預計腫瘤疾病細分市場在預測期內將以更高的年複合成長率成長。

依產品/軟體用途，市場細分為商業用途及臨床用途。目前，商業用途佔據遠距病人監護市場的最大佔有率。然而，臨床用途預計將展現最高的成長潛力，並且在預測期內，其年複合成長率將高於其他用途。

依商業模式類型，全球市場細分為B2C模式和B2B模式。目前，B2C和B2B市場各佔市場佔有率。然而，預計B2C遠距病人監護在未來幾年將顯著成長。

依主要地區劃分，市場細分為北美、歐洲、亞太地區、中東和北非以及拉丁美洲。目前，歐洲在全球遠距病人監護市場佔據主導地位，佔據最大的收入佔有率。此外，亞太地區市場在未來幾年的年複合成長率可能會更高。

遠距病患監護市場參與者

  • BioTelemetry
  • Braster
  • LeewayHertz
  • LifeWatch
  • Masimo
  • Medtronic
  • Siemens Healthineers
  • Transtek Medical.

目錄

第1章 簡介

第2章 執行摘要

第3章 簡介

  • 章節概述
  • 簡介
  • 遠距病患監護的優勢
  • 遠距患者監護的局限性
  • 遠距病患監護解決方案的監管考量
  • 結論

第4章 市場格局

  • 章節概述
  • 遠距病患監護諮詢工具與軟體：市場格局
  • 遠距病患監護諮詢工具和軟體：解決方案提供者格局

第5章 公司簡介

  • 章節概覽
  • 北美公司
    • BioTelemetry
    • LeewayHertz
    • Masimo
  • 歐洲公司
    • Braster
    • LifeWatch
    • Medtronic
    • Siemens Healthineers
  • 亞太地區公司
    • Transtek Medical

第6章 合作夥伴關係與合作

  • 章節概覽
  • 合作夥伴關係模式
  • 遠端病患監測諮詢工具與軟體供應商：近期合作夥伴關係與合作

第7章 融資與投資分析

  • 章節概述
  • 融資類型
  • 遠距病人監護諮詢工具和軟體供應商：融資和投資分析
  • 結論

第8章 產品競爭力分析

第9章 成本節約分析

  • 章節概述
  • 關鍵假設與研究方法
  • 遠距病人照護解決方案：整體成本節約潛力
  • 結論

第10章 市場預測

  • 章節概述
  • 預測研究方法與關鍵假設
  • 2035年全球遠距病人監護諮詢工具及軟體供應商市場
  • 全球遠距病人監護諮詢工具和軟體供應商市場：依應用領域
  • 全球遠距病人監護諮詢工具和軟體供應商市場：依治療領域
  • 全球遠端患者監測諮詢工具和軟體供應商市場：依軟體用途
  • 全球遠端病患監測諮詢工具和軟體供應商市場：依商業模式
  • 全球遠端患者監測諮詢工具和軟體供應商市場：依地區

第11章 COVID-19 疫情下的生物標記數位化解決方案市場對解決方案的影響

第12章 SWOT 分析

  • 章節概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅
  • SWOT 因素比較

第13章 結論

第14章 訪談記錄

第15章 附錄1：表格資料

第16章 附錄2：公司與組織清單

Product Code: RA100295

REMOTE PATIENT MONITORING MARKET: OVERVIEW

As per Roots Analysis, the global remote patient monitoring market is estimated to grow from USD 9.4 billion in the current year to USD 88.0 billion by 2035, at a CAGR of 25% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Software

  • System as a Software
  • System as a Service

Application Area

  • Blood Glucose
  • Blood Pressure
  • Body Temperature
  • Electrocardiogram
  • Oxygen Saturation
  • Respiration Rate
  • Others

Therapeutic Area

  • Cardiovascular Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

Product / Software Purpose

  • Commercial Purpose
  • Clinical Purpose

Type of Business Model

  • B2B
  • B2C

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

REMOTE PATIENT MONITORING MARKET: GROWTH AND TRENDS

Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. In fact, a recent report from the Center for Managing Chronic Disease at the University of Michigan reported that over 50% of the US population is affected by some form of chronic disease. Consequently, there is an urgent need for frequent monitoring to manage disease indications. However, some patients fail to report health issues to healthcare providers in time, which can lead to severe consequences and increased healthcare costs. In this context, remote patient monitoring has emerged as a potential solution for healthcare providers that enables them to monitor vital health signs in home care settings.

Remote Patient Monitoring Market - IMG1

The initiation of the concept of remote patient monitoring system (RPM) started nearly 200 years ago in 1800s. However, it wasn't until the introduction of cloud computing that the domain evolved at a significant pace. In fact, remote patient monitoring system solutions were gradually integrated into mainstream healthcare, specifically during the COVID-19 induced lockdown. These advanced tools and software solutions enabled and eased monitoring of patient health significantly during that period. These advanced devices utilize AI and biosensors to monitor vital signs like oxygen levels, blood pressure, heart rate, respiratory rate, blood glucose level, and other key signs in real time. Presently, several companies are focused on the development of remote patient monitoring systems.

REMOTE PATIENT MONITORING MARKET: KEY INSIGHTS

The report delves into the current state of the remote patient monitoring market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • At present, more than 170 players claim to have the required capabilities to offer remote patient monitoring solutions for use across a range of application areas.
  • Tools / software solutions for remote patient monitoring are being investigated across different types of software and are designed to target different therapeutic areas.
Remote Patient Monitoring Market - IMG2
  • In order to gain a competitive edge, remote patient monitoring solution developers are actively undertaking initiatives to integrate advanced features in their respective solutions and affiliated offerings.
  • Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary software solutions.
  • To support the ongoing innovation in this field, private and public investors have made substantial capital investments of worth USD 2.5 billion.
  • Given the favourable increase in demand for various remote patient monitoring solutions during the COVID-19 pandemic, the overall market is poised to grow at a CAGR of over 25%, till 2030.
Remote Patient Monitoring Market - IMG3
  • The projected opportunity is expected to be well distributed across different areas of application, types of business model and key geographical regions.

REMOTE PATIENT MONITORING MARKET: KEY SEGMENTS

System as a Software Segment holds the Largest Share of the Remote Patient Monitoring Market

Based on the type of software, the market is segmented into a system as a software and system as a service type of software. At present, the system as a software segment holds the maximum share of the global remote patient monitoring market. Further, the remote patient monitoring market for system as a service segment is expected to show the highest market growth potential during the forecast period owing to the growing demand for cloud-based solutions.

By Application Area, Electrocardiogram is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the application area, the market is segmented into blood glucose, blood pressure, body temperature, electrocardiogram, oxygen saturation, respiration rate and others. At present, the electrocardiogram segment holds the maximum share of the global remote patient monitoring market. This can be attributed to the growing prevalence of cardiovascular disorders that require constant monitoring of vital health parameters. Moreover, the market for electrocardiogram segment is expected to grow at a higher CAGR during the forecast period.

By Therapeutic Area, Metabolic Disorders Segment Accounts for the Largest Share of the Global Remote Patient Monitoring Market

Based on the therapeutic area, the market is segmented into cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorders, and others. Currently, the metabolic disorders segment captures the highest proportion of the global remote patient monitoring market. However, the oncological disorders segment is expected to grow at a higher CAGR during the forecast period.

By Product / Software Purpose, Commercial Purpose Segment is Likely to Dominate the Remote Patient Monitoring Market

Based on the product / software purpose, the market is segmented into commercial purpose and clinical purpose. At present, the commercial purpose segment holds the maximum share of the remote patient monitoring market. However, the clinical purpose segment is expected to show the highest growth potential during the forecast period, growing at a higher CAGR, compared to the other segments.

B2C is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the type of business model, the global market is segmented into B2C and B2B models. Currently, both B2C and B2B segments hold equal market share. However, the remote patient monitoring for B2C segment is expected to witness substantial growth in the coming years.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, Europe dominates the global remote patient monitoring market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Remote Patient Monitoring Market

  • BioTelemetry
  • Braster
  • LeewayHertz
  • LifeWatch
  • Masimo
  • Medtronic
  • Siemens Healthineers
  • Transtek Medical.

REMOTE PATIENT MONITORING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global remote patient monitoring market, focusing on key market segments, including [A] type of software, [B] application area, [C] therapeutic area, [D] product / software purpose, [E] type of business model and [F] key geographical regions.
  • Market Landscape: A comprehensive evaluation of the companies engaged in providing remote patient monitoring consultation tools and software, based on several relevant parameters, such as [A] year of establishment, [B] company size and [C] location of headquarters. Additionally, a comprehensive evaluation of consultation tools and software, based on several relevant parameters, such as [A] type of software, [B] area of application, [C] therapeutic areas, [D] product / software purpose, [E] type of telemedicine operation, [F] type of remote patient monitoring service and [G] type of business model.
  • Company Profiles: In-depth profiles of key players that are engaged in the development of remote patient monitoring software, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the remote patient monitoring market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of software, [E] most active players and [F] geographical distribution of the partnership activity.
  • Funding and Investments: An in-depth analysis of the fundings raised by remote patient monitoring companies, based on relevant parameters, such as [A] year of funding instances, [B] amount invested, [C] type of funding, [D] geographical analysis, [E] most active players and [F] most active investors.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of remote patient monitoring software, examining factors, such as [A] supplier power and [B] key product-related specifications.
  • Cost Saving Analysis: A comprehensive analysis of cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, examining factors, such as [A] number of patient visits and [B] increase in efficiency by adoption of remote patient monitoring software solutions.
  • Case Study: An insightful discussion on how the COVID-19 pandemic impacted the remote patient monitoring software market, accompanied by information on the important initiatives that were undertaken by players to overcome the challenges faced due to the pandemic.
  • SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of remote patient monitoring market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Introduction to Telemedicine
    • 3.2.1. Store-and-Forward Telemedicine
    • 3.2.2. Real-Time Telemedicine
    • 3.2.3. Telemedicine in Remote Patient Monitoring
  • 3.3. Advantages of Remote Patient Monitoring
  • 3.4. Limitations Associated with Remote Patient Monitoring
  • 3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
  • 3.6. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
    • 4.2.1. Analysis by Type of Software
    • 4.2.2. Analysis by Purpose of Software
    • 4.2.3. Analysis by Area of Application
    • 4.2.4. Analysis by Therapeutic Area
    • 4.2.5. Analysis by Type of Telemedicine Operation
    • 4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
    • 4.2.7. Analysis by Type of Business Model
  • 4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters

5. COMPANY PROFILES

  • 5.1. Chapter Overview
  • 5.2. Players based in North America
    • 5.2.1. BioTelemetry
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Financial Information
      • 5.2.1.3. Software Portfolio
      • 5.2.1.4. Future Outlook
    • 5.2.2. LeewayHertz
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Software Portfolio
      • 5.2.2.3. Future Outlook
    • 5.2.3. Masimo
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Financial Information
      • 5.2.3.3. Software Portfolio
      • 5.2.3.4. Future Outlook
  • 5.3. Players based in Europe
    • 5.3.1. Braster
      • 5.3.1.1. Company Overview
      • 5.3.1.2. Software Portfolio
      • 5.3.1.3. Future Outlook
    • 5.3.2. LifeWatch
      • 5.3.2.1. Company Overview
      • 5.3.2.2. Software Portfolio
      • 5.3.2.3. Future Outlook
    • 5.3.3. Medtronic
      • 5.3.3.1. Company Overview
      • 5.3.3.2. Financial Information
      • 5.3.3.3. Software Portfolio
      • 5.3.3.4. Future Outlook
    • 5.3.4. Siemens Healthineers
      • 5.3.4.1. Company Overview
      • 5.3.4.2. Financial Information
      • 5.3.4.3. Software Portfolio
      • 5.3.4.4. Future Outlook
  • 5.4. Players based in Asia-Pacific
    • 5.4.1. Transtek Medical
      • 5.4.1.1. Company Overview
      • 5.4.1.2. Financial Information
      • 5.4.1.3. Software Portfolio
      • 5.4.1.4. Future Outlook

6. PARTNERSHIPS AND COLLABORATIONS

  • 6.1. Chapter Overview
  • 6.2. Partnership Models
  • 6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
    • 6.3.1. Analysis by Year of Partnership
    • 6.3.2. Analysis by Type of Partnership
      • 6.3.2.1. Analysis by Year and Type of Partnership
      • 6.3.2.2. Analysis by Type of Partnership and Company Size
    • 6.3.3. Analysis by Type of Software
      • 6.3.3.1. Analysis by Year of Partnership and Type of Software
      • 6.3.3.2. Analysis by Type of Partnership and Type of Software
    • 6.3.4. Most Active Players: Analysis by Number of Partnerships
    • 6.3.5. Regional Analysis
      • 6.3.5.1. Intercontinental and Intracontinental Agreements

7. FUNDING AND INVESTMENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Types of Funding
  • 7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
    • 7.3.1. Analysis by Cumulative Year-wise Trend, Since 2015
    • 7.3.2. Analysis by Amount Invested
    • 7.3.3. Analysis by Type of Funding
      • 7.3.3.1. Analysis by Type of Venture Capital Round
    • 7.3.4. Analysis by Type of Software
    • 7.3.5. Analysis by Focus Area
    • 7.3.6. Analysis by Geography
    • 7.3.7. Most Active Players: Analysis by Number of Instances
    • 7.3.8. Most Active Players: Analysis by Amount Invested
    • 7.3.9. Most Active Investors: Analysis by Number of Instances
    • 7.3.10. Analysis by Year, Amount Invested and Type of Investor
  • 7.4. Concluding Remarks

8. PRODUCT COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Methodology
  • 8.3. Assumptions / Key Parameters
  • 8.4. Product Competitiveness: Software as a Service
  • 8.5. Product Competitiveness: Software as a System

9. COST SAVING ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Key Assumptions and Methodology
  • 9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential
    • 9.3.1. Likely Cost Savings in North America, Till 2035
    • 9.3.2. Likely Cost Savings in Europe, Till 2035
    • 9.3.3. Likely Cost Savings in Asia, Till 2035
    • 9.3.4. Likely Cost Savings in Rest of the World, Till 2035
  • 9.4. Conclusion

10. MARKET FORECAST

  • 10.1. Chapter Overview
  • 10.2. Forecast Methodology and Key Assumptions
  • 10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, Till 2035
  • 10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
    • 10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, Till 2035
    • 10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, Till 2035
    • 10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, Till 2035
    • 10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, Till 2035
    • 10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, Till 2035
    • 10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, Till 2035
    • 10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, Till 2035
  • 10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
    • 10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, Till 2035
    • 10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, Till 2035
    • 10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, Till 2035
    • 10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, Till 2035
    • 10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, Till 2035
    • 10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, Till 2035
  • 10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
    • 10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, Till 2035
    • 10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, Till 2035
  • 10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
    • 10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, Till 2035
    • 10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, Till 2035
  • 10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
    • 10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, Till 2035
    • 10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, Till 2035
    • 10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, Till 2035
    • 10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle East and North Africa (MENA), Till 2035
    • 10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, Till 2035

11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET

  • 11.1. Chapter Overview
  • 11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
    • 11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
  • 11.3. Recuperative Initiatives of Key Players
  • 11.4. Recuperative Strategies for Businesses
    • 11.4.1. Strategies for Implementation in the Short / Mid Term
    • 11.4.2. Strategies for Implementation in the Long Term

12. SWOT ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Strengths
  • 12.3. Weaknesses
  • 12.4. Opportunities
  • 12.5. Threats
  • 12.6. Comparison of SWOT Factors

13. CONCLUSION

14. INTERVIEW TRANSCRIPTS

  • 14.1. Chapter Overview
  • 14.2. Company A
    • 14.2.1. Company Snapshot
    • 14.2.2. Survey Transcript

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
  • Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
  • Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
  • Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
  • Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
  • Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 5.1 BioTel Care: Company Overview
  • Table 5.2 BioTel Care: Software Portfolio
  • Table 5.3 BioTel Care: Future Outlook
  • Table 5.4 LeewayHertz: Company Overview
  • Table 5.5 LeewayHertz: Software Portfolio
  • Table 5.6 Masimo: Company Overview
  • Table 5.7 Masimo: Software Portfolio
  • Table 5.8 Masimo: Future Outlook
  • Table 5.9 Braster: Company Overview
  • Table 5.10 Braster: Software Portfolio
  • Table 5.11 LifeWatch: Company Overview
  • Table 5.12 LifeWatch: Software Portfolio
  • Table 5.13 LifeWatch: Future Outlook
  • Table 5.14 Medtronic: Company Overview
  • Table 5.15 Medtronic: Software Portfolio
  • Table 5.16 Medtronic: Future Outlook
  • Table 5.17 Siemens Healthineers: Company Overview
  • Table 5.18 Siemens Healthineers: Software Portfolio
  • Table 5.19 Siemens Healthineers: Future Outlook
  • Table 5.20 Transtek Medical: Company Overview
  • Table 5.21 Transtek Medical: Software Portfolio
  • Table 5.22 Transtek Medical: Future Outlook
  • Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, Since 2015
  • Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, Since 2015
  • Table 7.2 Funding and Investment Analysis: Summary of Investments
  • Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
  • Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
  • Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
  • Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
  • Table 14.1 AltumView System: Company Snapshot
  • Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
  • Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
  • Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
  • Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
  • Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
  • Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
  • Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
  • Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
  • Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
  • Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
  • Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
  • Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
  • Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
  • Table 15.14 BioTel Care: Annual Revenues, Since 2015 (USD Million)
  • Table 15.15 Masimo: Annual Revenues, Since 2015 (USD Million)
  • Table 15.16 LifeWatch: Annual Revenues, Since 2015 (USD Million)
  • Table 15.17 Siemens Healthineers: Annual Revenues, Since 2015 (USD Million)
  • Table 15.18 Transtek Medical: Annual Revenues, Since 2015 (USD Million)
  • Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
  • Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
  • Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
  • Table 15.26 Most Active Players: Distribution by Number of Partnerships
  • Table 15.27 Partnerships and Collaborations: Regional Distribution
  • Table 15.28 Partnerships and Collaborations: Country-wise Distribution
  • Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, Since 2015
  • Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
  • Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
  • Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
  • Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
  • Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
  • Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
  • Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
  • Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
  • Table 15.40 Funding and Investment Analysis: Distribution by Geography
  • Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
  • Table 15.42 Most Active Players: Distribution by Number of Instances
  • Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
  • Table 15.44 Most Active Investors: Distribution by Number of Instances
  • Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
  • Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, Till 2035 (USD Million)
  • Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, Till 2035 (USD Million)
  • Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, Till 2035 (USD Million)
  • Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, Till 2035 (USD Million)
  • Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, Till 2035 (USD Million)
  • Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, Till 2035 (USD Million)
  • Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application
  • Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, Till 2035 (USD Million)
  • Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, Till 2035 (USD Million)
  • Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, Till 2035 (USD Million)
  • Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, Till 2035 (USD Million)
  • Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, Till 2035 (USD Million)
  • Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, Till 2035 (USD Million)
  • Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, Till 2035 (USD Million)
  • Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area
  • Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, Till 2035 (USD Million)
  • Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, Till 2035 (USD Million)
  • Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, Till 2035 (USD Million)
  • Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, Till 2035 (USD Million)
  • Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, Till 2035 (USD Million)
  • Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, Till 2035 (USD Million)
  • Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software
  • Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, Till 2035 (USD Million)
  • Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, Till 2035 (USD Million)
  • Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model
  • Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, Till 2035 (USD Million)
  • Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, Till 2035 (USD Million)
  • Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography
  • Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, Till 2035 (USD Million)
  • Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, Till 2035 (USD Million)
  • Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, Till 2035 (USD Million)
  • Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, Till 2035 (USD Million)
  • Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, Till 2035 (USD Million)
  • Table 15.79 Telemedicine in Remote Patient Monitoring Market, Till 2035: COVID-19 Impact Scenario (USD Million)

List of Figures

  • Figure 3.1 Type of Telemedicine
  • Figure 3.2 Steps Involved in Remote Patient Monitoring
  • Figure 3.3 Key Benefits and Limitations of RPM Solutions
  • Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
  • Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
  • Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
  • Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
  • Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
  • Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
  • Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
  • Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
  • Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
  • Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
  • Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
  • Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
  • Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
  • Figure 5.1 BioTel Care: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.2 Masimo: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.3 Medtronic: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.4 Siemens Healthineers: Annual Revenues, Since 2015 (USD Million)
  • Figure 5.5 Transtek Medical: Annual Revenues, Since 2015 (USD Million)
  • Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
  • Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
  • Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
  • Figure 6.8 Most Active Players: Distribution by Number of Partnerships
  • Figure 6.9 Partnerships and Collaborations: Regional Distribution
  • Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
  • Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, Since 2015
  • Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
  • Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
  • Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
  • Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
  • Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
  • Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
  • Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
  • Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
  • Figure 7.11 Funding and Investment Analysis: Distribution by Geography
  • Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
  • Figure 7.13 Most Active Players: Distribution by Number of Instances
  • Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
  • Figure 7.15 Most Active Investors: Distribution by Number of Instances
  • Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
  • Figure 8.1 Product Competitiveness Analysis: Software as a Service
  • Figure 8.2 Product Competitiveness Analysis: Software as a System
  • Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, Till 2035 (USD Million)
  • Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, Till 2035 (USD Million)
  • Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, Till 2035 (USD Million)
  • Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, Till 2035 (USD Million)
  • Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, Till 2035 (USD Million)
  • Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, Till 2035 (USD Million)
  • Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application
  • Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, Till 2035 (USD Million)
  • Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, Till 2035 (USD Million)
  • Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, Till 2035 (USD Million)
  • Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, Till 2035 (USD Million)
  • Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, Till 2035 (USD Million)
  • Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, Till 2035 (USD Million)
  • Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, Till 2035 (USD Million)
  • Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area
  • Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, Till 2035 (USD Million)
  • Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, Till 2035 (USD Million)
  • Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, Till 2035 (USD Million)
  • Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, Till 2035 (USD Million)
  • Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, Till 2035 (USD Million)
  • Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, Till 2035 (USD Million)
  • Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software
  • Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, Till 2035 (USD Million)
  • Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, Till 2035 (USD Million)
  • Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model
  • Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, Till 2035 (USD Million)
  • Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, Till 2035 (USD Million)
  • Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography
  • Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, Till 2035 (USD Million)
  • Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, Till 2035 (USD Million)
  • Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, Till 2035 (USD Million)
  • Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, Till 2035 (USD Million)
  • Figure 11.1 Remote Patient Monitoring Market, Till 2035: COVID-19 Impact Scenario (USD Million)
  • Figure 11.2 Key RPM Consultation Tools and Software Providers
  • Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
  • Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
  • Figure 13.1 Concluding Remarks: Current Market Landscape
  • Figure 13.2 Concluding Remarks: Recent Partnerships
  • Figure 13.3 Concluding Remarks: Funding Analysis
  • Figure 13.4 Concluding Remarks: Cost Saving Analysis
  • Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
  • Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography